Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.57 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.55 |
| ▸ | VCP | P55072 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.47 |
| ▸ | WNT3A | P56704 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15558301 | 0.91 | ALOX15 (0.60) | ACHEFGFR1VCPABL1RIN1 | |
| SCHEMBL4085618 | 0.87 | ALOX15 (0.54) | ACHEABL1RIN1ALOX15L3MBTL1 | |
| SCHEMBL11328763 | 0.86 | FGFR1 (0.55) | ACHEFGFR1VCPALOX15L3MBTL1 | |
| Propionic Acid SCHEMBL10451550 | 0.86 | ALOX15 (0.55) | ACHEFGFR1VCPABL1RIN1 | |
| SCHEMBL31321710 | 0.85 | ALOX15 (0.50) | ACHEALOX15L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL4085034 | 0.84 | TOP2A (0.56) | ACHEABL1RIN1ALOX15L3MBTL1 | |
| SCHEMBL4085193 | 0.83 | ALOX15 (0.55) | ACHEABL1RIN1ALOX15L3MBTL1 | |
| SCHEMBL4083743 | 0.83 | ELANE (0.55) | ACHEABL1RIN1ALOX15L3MBTL1 | |
| SCHEMBL4090515 | 0.83 | TOP2A (0.62) | ACHEABL1RIN1ALOX15L3MBTL1 | |
| SCHEMBL27728359 | 0.83 | CA12 (0.57) | FGFR1VCPALOX15ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119490612-A | Solid catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119490410-A | Ether ester compound, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-119490410-A | Ether ester compound, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-119490612-A | Solid catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-20230159841-A1 | MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | POLNOX CORPORATION | 2023-05-25 | — | — | US | disclosed |
| EP-2237683-B1 | METHOD OF FLAVORING | GIVAUDAN SA (CH) | 2015-11-11 | — | — | EP | disclosed |
| EP-2237683-B1 | METHOD OF FLAVORING | GIVAUDAN SA (CH) | 2015-11-11 | — | — | EP | disclosed |
| US-20130177688-A1 | Method of Flavoring | GIVAUDAN S.A. (CH) | 2013-07-11 | — | — | US | disclosed |
| US-20130177688-A1 | Method of Flavoring | GIVAUDAN S.A. (CH) | 2013-07-11 | — | — | US | disclosed |
| US-20130177688-A1 | Method of Flavoring | GIVAUDAN S.A. (CH) | 2013-07-11 | — | — | US | disclosed |
| US-20090186138-A1 | Method of Flavoring | GIVAUDAN SA (CH) | 2009-07-23 | — | — | US | disclosed |
| US-20090186138-A1 | Method of Flavoring | GIVAUDAN SA (CH) | 2009-07-23 | — | — | US | disclosed |
| US-20090186138-A1 | Method of Flavoring | GIVAUDAN SA (CH) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186138-A1 | Method of Flavoring | TAS2R5, TAS2R50, TAS2R10 | ACHE 3270/4885FGFR1 1509/4885VCP 3819/4885 |
| US-20230159841-A1 | MACROMOLECULAR CORROSION (MCIN) INHIBITORS: STRUCTURES, METHODS OF MAKING AND USING THE SAME | MB, NCLN, CPN1 | ACHE 358/4885FGFR1 3674/4885VCP 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.